MHR FUND MANAGEMENT LLC 13D/13G Filings for Iovance Biotherapeutics, Inc. (IOVA)

MHR FUND MANAGEMENT LLC 13D and 13G filings for Iovance Biotherapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-09
5:40 pm
Purchase		 2023-12-31 13G Iovance Biotherapeutics, Inc.
IOVA		 MHR FUND MANAGEMENT LLC 20,083,951
7.800%		 8,000,000increase
(+66.20%)		 Filing
2022-12-30
4:12 pm
Purchase		 2022-12-22 13G Iovance Biotherapeutics, Inc.
IOVA		 MHR FUND MANAGEMENT LLC 12,083,951
6.700%		 12,083,951increase
(New Position)		 Filing